Alnylam Pharmaceuticals (ALNY) Market Cap to FCF (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) Market Cap to FCF (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Market Cap to FCF |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | -852,075.83 |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | -49,404.47 |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -87,984.29 |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 379.13 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 32.87 |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | 16.99 |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | -6,011.75 |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 58.27 |
| 10 | Revolution Medicines | 37.05 Bn | 37.05 Bn | - | -34.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 23, 2026 | 55.51 |
| Jul 22, 2026 | 55.15 |
| Jul 21, 2026 | 56.06 |
| Jul 20, 2026 | 56.33 |
| Jul 17, 2026 | 55.25 |
| Jul 16, 2026 | 58.49 |
| Jul 15, 2026 | 57.66 |
| Jul 14, 2026 | 58.10 |
| Jul 13, 2026 | 59.50 |
| Jul 10, 2026 | 61.71 |
| Jul 9, 2026 | 64.61 |
| Jul 8, 2026 | 66.82 |
| Jul 7, 2026 | 66.43 |
| Jul 6, 2026 | 64.66 |
| Jul 2, 2026 | 64.61 |
| Jul 1, 2026 | 62.32 |
| Jun 30, 2026 | 62.18 |
| Jun 29, 2026 | 60.63 |
| Jun 26, 2026 | 60.19 |
| Jun 25, 2026 | 60.56 |